It's about feeling good while you do it
Semaglutide is a GLP-1 receptor agonist primarily used as a treatment for diabetes (Ozempic, Novo Nordisk) and more recently greenlit as a breakthrough treatment for obesity (Wegovy, Novo Nordisk)
Rapid weight loss from any cause increases the risk of gallstone formation, and we do see higher rates of cholelithiasis and cholecystitis in patients on GLP-1 medications, Dr
Of note, the mechanisms by which long-chain omega-3 PUFA supplements may reduce CHD death are unlikely to involve a lowering of triglycerides as doses used in the studies (~1 g/day) were generally too low (104)
Epub 2023 Nov 27
The SASP consists of a plethora of secreted factors, including pro-inflammatory cytokines, chemokines, growth factors, and extracellular matrix-degrading proteases, which profoundly influence the tissue microenvironment [56]